Krka d d : Releases 2023 Unaudited Financial Statements
March 14, 2024 at 04:26 am EDT
Share
HomeMedia centerNews 14. 3. 2024 3 min. read Krka released the 2023 unaudited financial statements of the Krka Group and the controlling company Krka, d. d., Novo mesto today. The report was published on the Ljubljana Stock Exchange website after being discussed by the Company's Supervisory Board at their meeting yesterday. The Krka Group generated [...]
This is an abstract of the document. To keep reading, click here and get access to the original version.
Attachments
Original Link
Permalink
Disclaimer
KRKA dd published this content on
14 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
14 March 2024 08:25:10 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
